CVS has announced the launch of CVS Pharmacy Rx Savings Finder, which will provide its 30,000 pharmacists the ability to find less expensive alternatives for their patients.
In an effort to help curb drug costs and provide more transparency, CVS is introducing a new tool to alert its pharmacists of cheaper drug options when they fill a patients’ prescriptions.
In a press release Wednesday, the company announced the launch of CVS Pharmacy Rx Savings Finder, which will provide its 30,000 pharmacists the ability to find less expensive alternatives for their patients. Pharmacists will be able to review a patient’s prescription regimen, medication history, and insurance plan information at the pharmacy counter.
Prescription drug prices remain a top concern for Americans. According to a recent national poll, commissioned by CVS Health, 83% of Americans voiced concern about the impact of rising prescription drug prices.
“Today’s consumers are faced with higher prescription drug prices than ever before, and many of them are now paying for a larger share of their prescription drug costs out of their own pockets at the pharmacy counter due to growth in high deductible health plans,” said Thomas Moriarty, chief policy and external affairs officer, CVS Health. “Until now, patients haven’t had the appropriate tools available to them to help manage these costs.”
The Savings Finder will work by sequentially alerting the pharmacist if:
The company is hoping that the program will also help with medication adherence. Kevin Hourican, executive vice president of retail pharmacy for CVS Pharmacy, noted that patients who are faced with high out-of-pocket costs at the pharmacy are less likely to pick up their prescription and are thus less likely to be adherent to their treatment regimen.
The program will first be made available to members of CVS’ pharmacy benefit manager branch, Caremark, and is expected to be rolled out more broadly throughout the year, according to Hourican.
CVS has also recently introduced a real-time benefits program to allow providers and their Caremark members to see the member-specific cost for a drug at the time of prescribing, as well as up to 5 of the lowest-cost, clinically appropriate therapeutic alternatives based on the patient’s formulary. According to the release, early results show that prescribers accessing the real-time benefits information switched their patient’s treatment from a non-covered drug to a drug on the formulary 85% of the time. When the patient’s drug was covered, prescribers switched the patient to a lower-cost alternative 30% of the time.
The launching of CVS Pharmacy Rx Savings Finder comes as the company is in the process of purchasing Aetna, with the idea of remaking the consumer healthcare experience by integrating doctors, pharmacists, and other health professionals with health benefits.
Bridging the Vaccination Gap: Insights on Global Immunization Challenges
July 30th 2024On this episode of Managed Care Cast, we speak with Jeffery A. Goad, PharmD, MPH, 2024-2025 president of the National Foundation for Infectious Diseases, on the recent report from the World Health Organization and UNICEF on public immunization rates, with national and global health implications.
Listen
Despite Record ACA Enrollment, Report Reveals Underinsured Americans Are in Crisis
November 21st 2024Despite significant progress in expanding health insurance coverage since the Affordable Care Act (ACA) was enacted, millions of Americans still face critical gaps in access to and affordability of health care.
Read More
Double Trouble: High-Deductible Plans Raise Maternity Care Costs Across 2 Calendar Years
June 27th 2024On this episode of Managed Care Cast, we're talking with the author of a study published in the June 2024 issue of The American Journal of Managed Care® about how annual high-deductible insurance plans increase maternity care costs when pregnancies cross 2 calendar years.
Listen
Uniting to Support Patients With Cancer Beyond Treatment
November 17th 2024Kasey Bond, MPH, of Perlmutter Cancer Center at NYU Langone Health, speaks to why it’s vital to keep patients at the center of all strategic partnerships between academic institutions and community-based oncology practices.
Read More
Support and Skepticism Emerge as Reactions to Robert F. Kennedy Jr’s HHS Nomination
November 15th 2024In the hours after President-elect Donald J. Trump tapped Robert F. Kennedy Jr to lead HHS, reactions came swiftly to the controversial pick who would have a large influence to shake up public health.
Read More